WallStreetZenWallStreetZen

NASDAQ: RGEN
Repligen Corp Earnings & Revenue

RGEN past earnings growth

How has RGEN's earnings growth performed historically?
Company
-90.73%
Industry
35.12%
Market
130.35%
RGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
RGEN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
RGEN's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

RGEN past revenue growth

How has RGEN's revenue growth performed historically?
Company
-21.9%
Industry
8.02%
Market
19.3%
RGEN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RGEN's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RGEN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RGEN earnings and revenue history

Current Revenue
$607.5M
Current Earnings
$14.8M
Current Profit Margin
2.4%
RGEN's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

RGEN Return on Equity

Current Company
0.8%
Current Industry
11.3%
Current Market
28.2%
RGEN's Return on Equity (0.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when RGEN announces earnings.

RGEN Return on Assets

Current Company
0.6%
Current Industry
7.7%
RGEN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

RGEN Return on Capital Employed

Current Company
1.38%
Current Industry
10.1%
RGEN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

RGEN vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
RGEN$607.45M$106.35M$14.84M+23.69%-10.22%
ATR$3.54B$700.23M$312.83M+4.77%+8.47%
TFX$3.00B$647.34M$294.87M+3.93%+9.19%
XRAY$3.94B$306.00M-$95.00M-0.18%N/A
STVN$1.16B$308.70M$146.43M+73.26%+36.15%

RGEN earnings dates

Next earnings date
Jul 31, 2024

Repligen Earnings & Revenue FAQ

What were RGEN's earnings last quarter?

On Invalid Date, Repligen (NASDAQ: RGEN) reported Q1 2024 earnings per share (EPS) of $0.04, up 92.31% year over year. Total Repligen earnings for the quarter were $2.09 million. In the same quarter last year, Repligen's earnings per share (EPS) was $0.52.

If you're new to stock investing, here's how to buy Repligen stock.

What was RGEN's earnings growth in the past year?

As of Q2 2024, Repligen's earnings has grown -90.73% year over year. This is 125.85 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 35.12%. Repligen's earnings in the past year totalled $14.84 million.

What is RGEN's earnings date?

Repligen's earnings date is Invalid Date. Add RGEN to your watchlist to be reminded of RGEN's next earnings announcement.

What was RGEN's revenue last quarter?

On Invalid Date, Repligen (NASDAQ: RGEN) reported Q1 2024 revenue of $151.35 million up 17.14% year over year. In the same quarter last year, Repligen's revenue was $182.66 million.

What was RGEN's revenue growth in the past year?

As of Q2 2024, Repligen's revenue has grown -21.9% year over year. This is 29.93 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 8.02%. Repligen's revenue in the past year totalled $607.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.